MannKind Corporation (MNKD): Price and Financial Metrics


MannKind Corporation (MNKD)

Today's Latest Price: $1.78 USD

0.03 (-1.66%)

Updated Jul 10 4:00pm

Add MNKD to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 338 in Biotech

See all "A" rated Strong Buy stocks

MNKD Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for MNKD is -0.31 -- better than merely 6.98% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -0.46 for Mannkind Corp; that's greater than it is for merely 6.34% of US stocks.
  • As for revenue growth, note that MNKD's revenue has grown 47.76% over the past 12 months; that beats the revenue growth of 89.25% of US companies in our set.
  • Stocks that are quantitatively similar to MNKD, based on their financial statements, market capitalization, and price volatility, are NR, ADMS, OPTN, ESTA, and ACRX.
  • Visit MNKD's SEC page to see the company's official filings. To visit the company's web site, go to www.mannkindcorp.com.
MNKD Daily Price Range
MNKD 52-Week Price Range

MNKD Stock Price Chart Technical Analysis Charts


MNKD Price/Volume Stats

Current price $1.78 52-week high $2.48
Prev. close $1.81 52-week low $0.80
Day low $1.77 Volume 2,298,878
Day high $1.84 Avg. volume 3,189,907
50-day MA $1.54 Dividend yield N/A
200-day MA $1.36 Market Cap 379.39M

MannKind Corporation (MNKD) Company Bio


MannKind Corporation focuses on the discovery, development, and commercialization of therapeutic products for diabetes in the United States. The company was founded in 1991 and is based in Valencia, California.


MNKD Latest News Stream


Event/TimeNews Detail
Loading, please wait...

MNKD Latest Social Stream


Loading social stream, please wait...

View Full MNKD Social Stream

Latest MNKD News From Around the Web

Below are the latest news stories about Mannkind Corp that investors may wish to consider to help them evaluate MNKD as an investment opportunity.

MannKind (MNKD) Presents At Lytham Partners Virtual Investor Growth Conference - Slideshow

The following slide deck was published by MannKind Corporation in conjunction with this event....

SA Transcripts on Seeking Alpha | June 26, 2020

MannKind Corporation (MNKD) CEO Michael Castagna Presents at Lytham Partners Virtual Investor Growth Conference (Transcript)

MannKind Corporation (MNKD) Lytham Partners Virtual Investor Growth Conference June 24, 2020 12:00 PM ET Company Participants Michael Castagna - CEO Conference Call Participants Robert Blum - Lytham Partners Presentation Robert Blum All right. Hello and thank you all for joining us today during the June 2020 Lytham Partners Virtual...

SA Transcripts on Seeking Alpha | June 24, 2020

MannKind Is Crushing It, but Beware or You'll Be Crushed

Before you consider going all in on MNKD stock, consider that the company is itself going all in on one product, and that comes with risks.

InvestorPlace | June 24, 2020

MannKind (MNKD) Looks Good: Stock Adds 5.5% in Session

MannKind (MNKD) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Yahoo | June 22, 2020

Implied Volatility Surging for MannKind (MNKD) Stock Options

Investors need to pay close attention to MannKind (MNKD) stock based on the movements in the options market lately.

Yahoo Finance | June 18, 2020

Read More 'MNKD' Stories Here

MNKD Price Returns

1-mo 25.35%
3-mo 53.45%
6-mo 15.58%
1-year 63.30%
3-year 34.85%
5-year -93.61%
YTD 37.98%
2019 21.70%
2018 -54.31%
2017 -27.50%
2016 -55.86%
2015 -72.22%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7653 seconds.